|
Volumn 5, Issue 1, 2003, Pages 57-58
|
Expression profilling predicts outcome in breast cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COMPLEMENTARY DNA;
ESTROGEN RECEPTOR;
TAMOXIFEN;
ESTROGEN RECEPTOR ALPHA;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER CLASSIFICATION;
CANCER RISK;
COHORT ANALYSIS;
DNA MICROARRAY;
GENE EXPRESSION PROFILING;
HUMAN;
LETTER;
METASTASIS;
OUTCOMES RESEARCH;
PREDICTION;
PROGNOSIS;
REPORTER GENE;
REPRODUCIBILITY;
RISK ASSESSMENT;
SENSITIVITY ANALYSIS;
VALIDATION PROCESS;
ASSAY;
CANCER PROGNOSIS;
DISTANT METASTASIS;
ESTROGEN RECEPTOR NEGATIVE BREAST CANCER;
ESTROGEN RECEPTOR POSITIVE BREAST CANCER;
MICROARRAY ANALYSIS;
RECEPTOR GENE;
TWO COLOR ASSAY;
BREAST TUMOR;
FEMALE;
GENE EXPRESSION REGULATION;
GENETICS;
METHODOLOGY;
NOTE;
PATHOLOGY;
PREDICTION AND FORECASTING;
SENSITIVITY AND SPECIFICITY;
STANDARD;
TUMOR RECURRENCE;
BREAST NEOPLASMS;
ESTROGEN RECEPTOR ALPHA;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
RECEPTORS, ESTROGEN;
SENSITIVITY AND SPECIFICITY;
|
EID: 0038576214
PISSN: 14655411
EISSN: None
Source Type: Journal
DOI: 10.1186/bcr562 Document Type: Letter |
Times cited : (155)
|
References (3)
|